NINGBO INNO PHARMCHEM CO.,LTD. is a leading supplier of essential chemical components for the pharmaceutical industry. Our product, D-(-)-Arabinose (CAS No. 28697-53-2), also known as Pectin Sugar or Nelarabine Intermediate, is a critical ingredient in the complex chemical synthesis of the important anti-cancer drug, Nelarabine.

The synthesis of Nelarabine is a multi-step process that requires precise chemical reactions and intermediates of exceptional purity. D-(-)-Arabinose serves as a foundational building block in this synthesis. Its specific chemical structure and reactivity are essential for constructing the final active pharmaceutical ingredient. The quality of this key precursor for Nelarabine synthesis directly impacts the efficiency of the overall process and the purity of the final drug product. NINGBO INNO PHARMCHEM CO.,LTD. guarantees that its D-(-)-Arabinose meets stringent pharmaceutical standards, including GMP, ISO 9001, and FDA certifications, ensuring its suitability for this demanding application. This adherence to quality is crucial for pharmaceutical manufacturers who depend on reliable and consistent raw materials.

Researchers and chemical engineers rely on a deep understanding of the chemical properties of D-(-)-Arabinose to optimize the synthetic routes for Nelarabine. Its characteristic white powder form allows for accurate handling and dosing in chemical reactions. The availability of this compound from a reputable supplier like NINGBO INNO PHARMCHEM CO.,LTD. facilitates seamless integration into manufacturing workflows. By ensuring a consistent and high-quality supply of CAS 28697-53-2, the company plays a vital role in ensuring that Nelarabine remains accessible for patients undergoing treatment for T-cell malignancies.

The commitment of NINGBO INNO PHARMCHEM CO.,LTD. to providing essential pharmaceutical intermediates like D-(-)-Arabinose underscores its dedication to the advancement of healthcare. Reliable sourcing of high-quality D-(-)-Arabinose is not merely a transaction; it is a critical partnership that supports the entire pharmaceutical value chain. From initial research and development to large-scale manufacturing, having a trusted supplier for such vital chemical building blocks is indispensable for bringing effective treatments to market and improving patient lives.